NCT00270465View on ClinicalTrials.gov

Safety and Immune Response to a Prime-Boost Vaccination Schedule in HIV-infected Patients

PHASE1CompletedINTERVENTIONAL
Enrollment

17

Participants

Timeline

Start Date

December 21, 2005

Primary Completion Date

June 25, 2009

Study Completion Date

June 25, 2009

Conditions
HIV
Interventions
DRUG

VRC-HIVDNA016-00-VP

DRUG

VRC-HIVADV014-00-VP

Trial Locations (1)

20892

National Institutes of Health Clinical Center, 9000 Rockville Pike, Bethesda

All Listed Sponsors
lead

National Institute of Allergy and Infectious Diseases (NIAID)

NIH

NCT00270465 - Safety and Immune Response to a Prime-Boost Vaccination Schedule in HIV-infected Patients | Biotech Hunter | Biotech Hunter